Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant (Q43946898)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant |
scientific article |
Statements
1 reference
Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant (English)
1 reference
Anne Klibanski
1 reference
Mary Lee Vance
1 reference
Gemma Sesmilo
1 reference
Wesley P Fairfield
1 reference
Laurence Katznelson
1 reference
Karen Pulaski
1 reference
Pamela U Freda
1 reference
Vivien Bonert
1 reference
Eleni Dimaraki
1 reference
Stavros Stavrou
1 reference
Douglas Hayden
1 reference
1 April 2002
1 reference
1 reference
87
1 reference
4
1 reference
1692-1699
1 reference
Identifiers
1 reference
1 reference